Haemonetics Corporation

Haemonetics Corporationverified

HAE

Price:

$88.34

Market Cap:

$4.49B

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the do...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

1991-05-10

Stock Exchange

NYSE

Ticker

HAE

The PE Ratio as of May 2024 (TTM) for Haemonetics Corporation (HAE) is 38.58

According to Haemonetics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 38.58. This represents a change of -3.41% compared to the average of 39.94 of the last 4 quarters.

Haemonetics Corporation (HAE) Historical PE Ratio (quarterly & annually)

How has HAE PE Ratio performed in the past?

The mean historical PE Ratio of Haemonetics Corporation over the last ten years is 47.63. The current 38.58 PE Ratio has changed 8.00% with respect to the historical average. Over the past ten years (40 quarters), HAE's PE Ratio was at its highest in in the June 2020 quarter at 104.89. The PE Ratio was at its lowest in in the June 2015 quarter at -2019.78.

Quarterly (TTM)
Annual

Average

47.63

Median

69.17

Minimum

-79.55

Maximum

134.83

Haemonetics Corporation (HAE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Haemonetics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 185.97%

Maximum Annual PE Ratio = 134.83

Minimum Annual Increase = -206.46%

Minimum Annual PE Ratio = -79.55

Quarterly (TTM)
Annual
YearPE RatioChange
202436.811.10%
202336.41-51.54%
202275.145.15%
202171.466.87%
202066.87-18.39%
201981.94-3.25%
201884.69-206.46%
2017-79.55146.27%
2016-32.30-123.96%
2015134.83185.97%

Haemonetics Corporation (HAE) Average PE Ratio

How has HAE PE Ratio performed in the past?

The current PE Ratio of Haemonetics Corporation (HAE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

49.46

5-year avg

57.34

10-year avg

47.63

Haemonetics Corporation (HAE) PE Ratio vs. Peers

How is HAE’s PE Ratio compared to its peers?

Haemonetics Corporation’s PE Ratio is less than Merit Medical Systems, Inc. (46.57), greater than AngioDynamics, Inc. (-1.29), greater than AptarGroup, Inc. (31.27), greater than Envista Holdings Corporation (-26.06), greater than Hologic, Inc. (37.32), greater than ICU Medical, Inc. (-41.52), less than The Cooper Companies, Inc. (64.74), greater than Teleflex Incorporated (32.94), less than West Pharmaceutical Services, Inc. (42.86), less than Alcon Inc. (42.14), greater than ResMed Inc. (32.70), greater than Akoya Biosciences, Inc. (-1.42), greater than AtriCure, Inc. (-29.10), less than Atrion Corporation (43.53),

Build a custom stock screener for Haemonetics Corporation (HAE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Haemonetics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Haemonetics Corporation (HAE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Haemonetics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Haemonetics Corporation's PE Ratio?

How is the PE Ratio calculated for Haemonetics Corporation (HAE)?

What is the highest PE Ratio for Haemonetics Corporation (HAE)?

What is the 3-year average PE Ratio for Haemonetics Corporation (HAE)?

What is the 5-year average PE Ratio for Haemonetics Corporation (HAE)?

How does the current PE Ratio for Haemonetics Corporation (HAE) compare to its historical average?